adverse effects following immunisation (AEFI), according to an article in the Medical
Journal of Australia.
Dr Michael Gold, Senior Lecturer in Paediatrics at the University of Adelaide, and co-authors
reviewed Australia's response to AEFI such as febrile convulsions in children aged five years
and under after the seasonal trivalent influenza vaccine was administered.
Dr Gold said that, in Australia, the current mechanism for identifying AEFI nationally is
passive surveillance.
"Passive surveillance relies on health providers and the public recognising and reporting
suspected AEFI to state or federal health authorities," Dr Gold said.
"The inability of the existing surveillance systems to detect the early signal of an increased
incidence of febrile convulsions, within 24 hours of receiving 2010 seasonal trivalent
influenza vaccine, demonstrates that passive surveillance cannot be relied on as the sole
means of surveillance.
"The way forward is to establish a coordinated, uniform approach to AEFI reporting, coding,
collation and analysis.
"A standing vaccine safety monitoring group which includes key stakeholders - representing
the regulators, state and national immunisation programs, and vaccine safety and
epidemiology experts - needs to be urgently established.
"In the aftermath of the 2010 seasonal trivalent influenza vaccine experience, maintaining the
public's trust requires that we get started on building the fully functional, standard-of-care
AEFI surveillance system that Australia deserves.
"Vaccine safety should be an integral component of the National Immunisation Strategy,
which should include strategies for comprehensive and complementary passive and active
systems of surveillance."
The Medical Journal of Australia is a publication of the Australian Medical Association.
Source:
Medical Journal of Australia
Recommendations:
• Buy Robaxin without Prescription
• Buy Cafergot without Prescription
• Buy Skelaxin without Prescription
Nenhum comentário:
Postar um comentário